We Invest in insureds who have a terminal illness.
We purchase life insurance policies from persons who have a life
expectancy of a few weeks to a few months at 20 cents on the dollar.
We become the beneficiaries.
We then either cash out the life policy and or obtain loans against them or collect upon maturity or trade them to exit purchasers in the secondary market.
Right now we are looking for an investor partner to partner in on a
transaction of a 3 million dollar policy, split between 3 partners or a 5
million dollar policy.
An Investment of $78,000.00 will yield $1 million in a few months.
Here is the scenario, the insured has been diagnosed with end stage renal disease, HIV, MS, and Cancer of the Lymph Nodes.
The tumor is now malignant and has metastasized throughout the body affecting the liver. The cumulative effect has increased the number of co-morbidities as indicated by high mortality of the insured. Life Expectancy is predicted to 3-6 months at best.
(The rate of return is determined by the mortality and or morbidity of the insured, in some cases if the insured lives for another year or two this may influence the rate of return)
If interested private message me as adverisements are not allowed
Earlier this year, a company called Life Partners declared bankruptcy. They had a pretty simple business model: they brought together investors and dying people in need of cash. The investors put up some money and paid the life insurance premiums, collecting the insurance payout when the person eventually dies. This business model doesn’t work out for the investor, though, when the insured person lives longer than anticipated.
While the invention of advanced anti-retroviral drug cocktails to control HIV has been a good thing for humanity overall, it was not a good thing for the life settlements business. That’s the business of buying out life insurance policies so a terminally ill person has some cash to live on: people also call them “death bonds.”
The business isn’t inherently evil, but it becomes evil when a company deliberately under-estimates how long a person can be expected to live for the purpose of calculating their cash payout and when selling potential investors on the idea. Life partners brought together people to own shares of a dying person’s policy, telling them what the anticipated payout would be and how long the person was expected to live. The problem? The patients didn’t die.
From a human point of view, that’s great news. From the point of view of an investor stuck paying the person’s life insurance premiums, that’s a disaster. Life Partners sold shares of life insurance policies to individual investors and to asset managers, but a federal jury found the company guilty by of deliberately under-estimating how long insured people would live.
Life Partners filed for bankruptcy after it was ordered to pay a judgement of $46 million by the Securities and Exchange Commission, but what complicates liquidating the company is that investments are tied up in the life insurance policies of people who still haven’t died.
Bloomberg uses the example of one woman who bought a share of a policy in 2001. She put up $25,000, and the man was expected to die within 18 months. When his life insurance paid out, she would receive $30,000. The man hasn’t yet died, and her share of his life insurance premiums in the interim has been $8,000. This turned out to be a poor investment.